联环药业: 联环药业董事、高级管理人员所持本公司股份及其变动管理办法（2025年8月修订）

General Provisions - The management measures for the shares held by the company's directors and senior management are established to strengthen the management of shareholding and changes, in accordance with relevant laws and regulations [1][2] - These measures apply to the shares held by directors, senior management, and other specified individuals or organizations [1] Share Trading Regulations - Directors and senior management must ensure their securities accounts are not operated by others and must report accurate personal information to the stock exchange [2] - Share trading must be reported within two trading days after changes in personal information or after leaving their positions [2][3] Restrictions on Share Transfers - Directors and senior management are prohibited from reducing their shareholdings under certain conditions, such as within six months of leaving the company or during investigations for securities violations [4][5] - Specific periods are defined during which directors and senior management cannot buy or sell shares, including 15 days before annual or semi-annual reports [5][6] Disclosure Requirements - Any changes in shareholdings must be reported within two trading days, including details such as the number of shares before and after the change [9][10] - A reduction plan must include the number of shares, time frame, and reasons for the reduction, and must be reported to the stock exchange [11] Responsibilities and Penalties - Violations of these regulations can lead to warnings, disciplinary actions, or civil liability for the responsible individuals [13][14] - The company must maintain complete records of any violations and report them to regulatory authorities as required [13]